Literature DB >> 19752033

Role for the Burkholderia pseudomallei capsular polysaccharide encoded by the wcb operon in acute disseminated melioidosis.

Jonathan M Warawa1, Dan Long, Rebecca Rosenke, Don Gardner, Frank C Gherardini.   

Abstract

The capsular polysaccharide of Burkholderia pseudomallei is an essential virulence determinant that is required for protection from host serum cidal activity and opsonophagocytosis. In this study, the immune response directed against a B. pseudomallei capsule mutant (JW270) was investigated in an acute respiratory murine model. JW270 was significantly attenuated in this model ( approximately 2 logs) to levels resembling those of avirulent Burkholderia thailandensis. At lethal doses, JW270 colonized the lung, liver, and spleen at levels similar to the wild-type strain levels and was found to trigger reduced pathology in the liver and spleen. Several cytokine responses were altered in these tissues, and importantly, the levels of gamma interferon were reduced in the livers and spleens of JW270-infected mice but not in the lungs. These results suggest that the capsular polysaccharide of B. pseudomallei is a critical virulence determinant in respiratory tract infections and that it is an important antigen for generating the Th1 immune response commonly observed in systemic melioidosis. Furthermore, the data suggest that host recognition of B. pseudomallei capsular polysaccharide in the lungs may not be as important to the disease outcome as the innate immune response in the peripheral organs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19752033      PMCID: PMC2786491          DOI: 10.1128/IAI.00824-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

1.  A type IV pilin, PilA, Contributes To Adherence of Burkholderia pseudomallei and virulence in vivo.

Authors:  Angela E Essex-Lopresti; Justin A Boddey; Richard Thomas; Martin P Smith; M Gill Hartley; Timothy Atkins; Nat F Brown; Chuk Hai Tsang; Ian R A Peak; Jim Hill; Ifor R Beacham; Richard W Titball
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

2.  Development of signature-tagged mutagenesis in Burkholderia pseudomallei to identify genes important in survival and pathogenesis.

Authors:  J Cuccui; A Easton; K K Chu; G J Bancroft; P C F Oyston; R W Titball; B W Wren
Journal:  Infect Immun       Date:  2006-12-22       Impact factor: 3.441

3.  Aerogenic vaccination with a Burkholderia mallei auxotroph protects against aerosol-initiated glanders in mice.

Authors:  Ricky L Ulrich; Kei Amemiya; David M Waag; Chad J Roy; David DeShazer
Journal:  Vaccine       Date:  2005-03-14       Impact factor: 3.641

4.  Identification of Burkholderia pseudomallei genes required for the intracellular life cycle and in vivo virulence.

Authors:  Sabine Pilatz; Katrin Breitbach; Nadine Hein; Beate Fehlhaber; Jessika Schulze; Birgit Brenneke; Leo Eberl; Ivo Steinmetz
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

5.  Virulence of clinical and environmental isolates of Burkholderia oklahomensis and Burkholderia thailandensis in hamsters and mice.

Authors:  David Deshazer
Journal:  FEMS Microbiol Lett       Date:  2007-12       Impact factor: 2.742

Review 6.  Role of chemokines in endocrine autoimmune diseases.

Authors:  Mario Rotondi; Luca Chiovato; Sergio Romagnani; Mario Serio; Paola Romagnani
Journal:  Endocr Rev       Date:  2007-05-02       Impact factor: 19.871

7.  Indirect hemagglutination assay in patients with melioidosis in northern Australia.

Authors:  Allen C Cheng; Mathew O'brien; Kevin Freeman; Gary Lum; Bart J Currie
Journal:  Am J Trop Med Hyg       Date:  2006-02       Impact factor: 2.345

8.  A live experimental vaccine against Burkholderia pseudomallei elicits CD4+ T cell-mediated immunity, priming T cells specific for 2 type III secretion system proteins.

Authors:  Ashraful Haque; Karen Chu; Anna Easton; Mark P Stevens; Edouard E Galyov; Tim Atkins; Rick Titball; Gregory J Bancroft
Journal:  J Infect Dis       Date:  2006-09-25       Impact factor: 5.226

9.  Bacterial genome adaptation to niches: divergence of the potential virulence genes in three Burkholderia species of different survival strategies.

Authors:  H Stanley Kim; Mark A Schell; Yan Yu; Ricky L Ulrich; Saul H Sarria; William C Nierman; David DeShazer
Journal:  BMC Genomics       Date:  2005-12-07       Impact factor: 3.969

10.  The innate interferon gamma response of BALB/c and C57BL/6 mice to in vitro Burkholderia pseudomallei infection.

Authors:  Ghee Chong Koo; Yunn-Hwen Gan
Journal:  BMC Immunol       Date:  2006-08-18       Impact factor: 3.615

View more
  22 in total

1.  Antibodies against In Vivo-Expressed Antigens Are Sufficient To Protect against Lethal Aerosol Infection with Burkholderia mallei and Burkholderia pseudomallei.

Authors:  Shawn M Zimmerman; Jeremy S Dyke; Tomislav P Jelesijevic; Frank Michel; Eric R Lafontaine; Robert J Hogan
Journal:  Infect Immun       Date:  2017-07-19       Impact factor: 3.441

2.  Role for Rhizobium rhizogenes K84 cell envelope polysaccharides in surface interactions.

Authors:  Ana M Abarca-Grau; Lindsey P Burbank; Héctor D de Paz; Juan C Crespo-Rivas; Ester Marco-Noales; María M López; Jose M Vinardell; Susanne B von Bodman; Ramón Penyalver
Journal:  Appl Environ Microbiol       Date:  2011-12-30       Impact factor: 4.792

3.  Alteration of the phenotypic and pathogenic patterns of Burkholderia pseudomallei that persist in a soil environment.

Authors:  Yao-Shen Chen; Wun-Ju Shieh; Cynthia S Goldsmith; Maureen G Metcalfe; Patricia W Greer; Sherif R Zaki; Hsin-Hou Chang; Hao Chan; Ya-Lei Chen
Journal:  Am J Trop Med Hyg       Date:  2014-01-20       Impact factor: 2.345

4.  Characterization of the Burkholderia pseudomallei K96243 capsular polysaccharide I coding region.

Authors:  Jon Cuccui; Timothy S Milne; Nicholas Harmer; Alison J George; Sarah V Harding; Rachel E Dean; Andrew E Scott; Mitali Sarkar-Tyson; Brendan W Wren; Richard W Titball; Joann L Prior
Journal:  Infect Immun       Date:  2012-01-17       Impact factor: 3.441

5.  Burkholderia pseudomallei Capsule Exacerbates Respiratory Melioidosis but Does Not Afford Protection against Antimicrobial Signaling or Bacterial Killing in Human Olfactory Ensheathing Cells.

Authors:  Samantha J Dando; Deepak S Ipe; Michael Batzloff; Matthew J Sullivan; David K Crossman; Michael Crowley; Emily Strong; Stephanie Kyan; Sophie Y Leclercq; Jenny A K Ekberg; James St John; Ifor R Beacham; Glen C Ulett
Journal:  Infect Immun       Date:  2016-06-23       Impact factor: 3.441

6.  Contribution of murine IgG Fc regions to antibody binding to the capsule of Burkholderia pseudomallei.

Authors:  Michael J Dillon; Rachael A Loban; Dana E Reed; Peter Thorkildson; Kathryn J Pflughoeft; Sujata G Pandit; Paul J Brett; Mary N Burtnick; David P AuCoin
Journal:  Virulence       Date:  2016-04-20       Impact factor: 5.882

7.  Neutrophil extracellular traps exhibit antibacterial activity against burkholderia pseudomallei and are influenced by bacterial and host factors.

Authors:  Donporn Riyapa; Surachat Buddhisa; Sunee Korbsrisate; Jon Cuccui; Brendan W Wren; Mark P Stevens; Manabu Ato; Ganjana Lertmemongkolchai
Journal:  Infect Immun       Date:  2012-08-27       Impact factor: 3.441

Review 8.  Development of Burkholderia mallei and pseudomallei vaccines.

Authors:  Ediane B Silva; Steven W Dow
Journal:  Front Cell Infect Microbiol       Date:  2013-03-11       Impact factor: 5.293

9.  Capsule influences the deposition of critical complement C3 levels required for the killing of Burkholderia pseudomallei via NADPH-oxidase induction by human neutrophils.

Authors:  Michael E Woodman; Randall G Worth; R Mark Wooten
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

10.  A non-invasive intratracheal inoculation method for the study of pulmonary melioidosis.

Authors:  David A Revelli; Julie A Boylan; Frank C Gherardini
Journal:  Front Cell Infect Microbiol       Date:  2012-12-20       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.